[
  {
    "ts": null,
    "headline": "Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill",
    "summary": "Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.",
    "url": "https://finnhub.io/api/news?id=25e70e563857c593b38edcc95b88cc6e0a3476e0c2c49a1f7826394b1e8ffa1d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745352363,
      "headline": "Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill",
      "id": 134038727,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.",
      "url": "https://finnhub.io/api/news?id=25e70e563857c593b38edcc95b88cc6e0a3476e0c2c49a1f7826394b1e8ffa1d"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Warns on Pfizer (PFE): “That 7.7% Yield Is Not a Sign of Strength – It’s a Sign of Weakness”",
    "summary": "We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discussed. On Thursday’s episode of Mad Money, Jim Cramer addressed the growing friction between Federal Reserve Chairman Jerome Powell and […]",
    "url": "https://finnhub.io/api/news?id=b80862c7cfc0ef210570d50ed143d3bb2b7559dce3afc8dfd5a4386e2c1a53bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745343890,
      "headline": "Jim Cramer Warns on Pfizer (PFE): “That 7.7% Yield Is Not a Sign of Strength – It’s a Sign of Weakness”",
      "id": 134039031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discussed. On Thursday’s episode of Mad Money, Jim Cramer addressed the growing friction between Federal Reserve Chairman Jerome Powell and […]",
      "url": "https://finnhub.io/api/news?id=b80862c7cfc0ef210570d50ed143d3bb2b7559dce3afc8dfd5a4386e2c1a53bf"
    }
  },
  {
    "ts": null,
    "headline": "Stocks That Pay Almost 10% Dividend Yields: Dow and Lyondell",
    "summary": "Chemicals firms Dow and LyondellBasell are the biggest dividend payers in the S&P 500. Other fat divided payouts include Pfizer, Franklin Resources, and Invesco.",
    "url": "https://finnhub.io/api/news?id=7fa7f05ff72f18c02f4adb2697c362a8c812491ea1b9c89da5d411fab8e2495b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745342280,
      "headline": "Stocks That Pay Almost 10% Dividend Yields: Dow and Lyondell",
      "id": 134039032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Chemicals firms Dow and LyondellBasell are the biggest dividend payers in the S&P 500. Other fat divided payouts include Pfizer, Franklin Resources, and Invesco.",
      "url": "https://finnhub.io/api/news?id=7fa7f05ff72f18c02f4adb2697c362a8c812491ea1b9c89da5d411fab8e2495b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock rises Tuesday, still underperforms market",
    "summary": "Pfizer Inc. stock rises Tuesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=0e048f4937c1a5fc5f169c600ebeb50ad869f7c098089c36de97b530dc3ae022",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745339760,
      "headline": "Pfizer Inc. stock rises Tuesday, still underperforms market",
      "id": 134055309,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock rises Tuesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=0e048f4937c1a5fc5f169c600ebeb50ad869f7c098089c36de97b530dc3ae022"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for",
    "summary": "Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=cadfb75df9ecba8f285f1ee1fdde4e0c88f3ff9c1149127089d9d5f092c0a85e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745330458,
      "headline": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for",
      "id": 134038509,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=cadfb75df9ecba8f285f1ee1fdde4e0c88f3ff9c1149127089d9d5f092c0a85e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE): Among Recent Activist Investor Campaigns",
    "summary": "We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other recent activist investor campaigns. Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025. In the first quarter alone, there […]",
    "url": "https://finnhub.io/api/news?id=80762bd0b633e36400b11d2aced4546bcfabb20939d81417266131ce436feb2d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745328964,
      "headline": "Pfizer Inc. (PFE): Among Recent Activist Investor Campaigns",
      "id": 134039034,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other recent activist investor campaigns. Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025. In the first quarter alone, there […]",
      "url": "https://finnhub.io/api/news?id=80762bd0b633e36400b11d2aced4546bcfabb20939d81417266131ce436feb2d"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know",
    "summary": "Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=c3f6a5000e03d2f7df94758124317b6f6f8b8077266f2e4d814320d342110ae7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745326814,
      "headline": "Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know",
      "id": 134039035,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=c3f6a5000e03d2f7df94758124317b6f6f8b8077266f2e4d814320d342110ae7"
    }
  },
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Initiates Coverage of Pfizer (PFE) with Neutral Recommendation",
    "summary": "Cantor Fitzgerald Initiates Coverage of Pfizer (PFE) with Neutral Recommendation",
    "url": "https://finnhub.io/api/news?id=e7da6e44eee381f1b9e22de4454449797045573bd8e4c5f732139482207daa56",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745323464,
      "headline": "Cantor Fitzgerald Initiates Coverage of Pfizer (PFE) with Neutral Recommendation",
      "id": 134032759,
      "image": "",
      "related": "PFE",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e7da6e44eee381f1b9e22de4454449797045573bd8e4c5f732139482207daa56"
    }
  },
  {
    "ts": null,
    "headline": "Novo shares down on Eli Lilly’s positive obesity pill data",
    "summary": "Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron, which showed weight loss and blood sugar control comparable to injectable treatments like Ozempic.",
    "url": "https://finnhub.io/api/news?id=12a2903aee1abc5b30e13f7dfc6b0744ff18246f16c345acf4be49080918ea90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745310841,
      "headline": "Novo shares down on Eli Lilly’s positive obesity pill data",
      "id": 134031146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron, which showed weight loss and blood sugar control comparable to injectable treatments like Ozempic.",
      "url": "https://finnhub.io/api/news?id=12a2903aee1abc5b30e13f7dfc6b0744ff18246f16c345acf4be49080918ea90"
    }
  },
  {
    "ts": null,
    "headline": "Celldex Therapeutics: Strong Pipeline But Uncertainties Remain",
    "summary": "Celldex Therapeutics: Strong Pipeline But Uncertainties Remain",
    "url": "https://finnhub.io/api/news?id=86d41e896994b5a6991acd7c35e1ad930214df3a07b4d63cfe849368b7cbc0dd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745307622,
      "headline": "Celldex Therapeutics: Strong Pipeline But Uncertainties Remain",
      "id": 134032095,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=86d41e896994b5a6991acd7c35e1ad930214df3a07b4d63cfe849368b7cbc0dd"
    }
  }
]